Impact Healthcare REIT PLC is a real estate investment trust. The Company provides shareholders with an attractive return, by investing in a diversified portfolio of United Kingdom healthcare real estate assets, in particular residential and nursing care homes. Its strategy is to identify new healthcare properties and tenants who diversify its portfolio and deliver economies of scale.
It works with its tenants to implement asset management opportunities that benefit the tenant, residents, and shareholders. Its objective is to provide shareholders with attractive and sustainable returns, in the form of quarterly dividends, while also generating growth in net asset values over the medium term.
It acquires, owns, leases, renovates, extends, redevelops healthcare real estate assets in the United Kingdom, in particular elderly care homes, and to lease those assets to care home operators and other healthcare service providers. The Company's investment manager is Impact Health Partners LLP..
Price and Volume | |
---|---|
Volume | |
Ten Day Average Volume | 351.6K |
Three Month Average Volume | 9.4M |
High Low | |
Fifty-Two Week High | 0.92 GBX |
Fifty-Two Week Low | 0.771 GBX |
Fifty-Two Week High Date | 01 Sep 2023 |
Fifty-Two Week Low Date | 26 Oct 2023 |
Price and Volume | |
Current Price | 0.889 GBX |
Beta | 1 |
Relative Price Change | |
Four Week Relative Price Change | -0.44% |
Thirteen Week Relative Price Change | -0.29% |
Twenty-Six Week Relative Price Change | 0.40% |
Fifty-Two Week Relative Price Change | -13.92% |
Year-to-Date Relative Price Change | -8.76% |
Price Change | |
One Day Price Change | 0.79% |
Thirteen Week Price Change | 1.02% |
Twenty-Six Week Price Change | 9.48% |
Five Day Price Change | 0.00% |
Fifty-Two Week Price Change | -2.95% |
Year-to-Date Price Change | -1.33% |
Month-to-Date Price Change | 1.48% |
Per Share Data | |
---|---|
Book Value | |
Book Value Per Share (Last Fiscal Year) | 1.15382 GBX |
Book Value Per Share (Most Recent Quarter) | 1.18307 GBX |
Tangible Book Value Per Share (Last Fiscal Year) | 1.15382 GBX |
Tangible Book Value Per Share (Most Recent Quarter) | 1.18307 GBX |
EBITD | |
EBITD Per Share (Trailing Twelve Months) | 0.11222 GBX |
Revenue | |
Revenue Per Share (Last Fiscal Year) | 0.12201 GBX |
Revenue Per Share (Trailing Twelve Months) | 0.13079 GBX |
Dividend | |
Dividend Per Share (Last Fiscal Year) | 0.05416 GBX |
Dividend Per Share (Trailing Twelve Months) | 0.05488 GBX |
Dividend Per Share (5 Year) | 0.05242 GBX |
Earnings Per Share | |
Excluding Extraordinary Items (Last Fiscal Year) | 0.1179 GBX |
Excluding Extraordinary Items (Trailing Twelve Months) | 0.11481 GBX |
Normalized (Last Fiscal Year) | 0.1179 GBX |
Basic Excluding Extraordinary Items (Last Fiscal Year) | 0.1179 GBX |
Basic Excluding Extraordinary Items (Trailing Twelve Months) | 0.11481 GBX |
Including Extraordinary Items (Last Fiscal Year) | 0.1179 GBX |
Including Extraordinary Items (Trailing Twelve Months) | 0.11481 GBX |
Cash | |
Cash Per Share (Last Fiscal Year) | 0.02266 GBX |
Cash Per Share (Most Recent Quarter) | 0.02313 GBX |
Cash Flow Per Share (Last Fiscal Year) | -99999.99 GBX |
Cash Flow Per Share (Trailing Twelve Months) | -99999.99 GBX |
Free Cash Flow Per Share (Trailing Twelve Months) | -0.00092 GBX |
Margins | |
---|---|
Cash Flow Revenue | |
Cash Flow Revenue (5 Year) | -8 |
Cash Flow Revenue (Trailing Twelve Months) | -1 |
Pretax Margin | |
Pretax Margin (Trailing Twelve Months) | 87.79% |
Pretax Margin (Last Fiscal Year) | 96.64% |
Pretax Margin (5 Year) | 82.24% |
Gross Margin | |
Gross Margin (Last Fiscal Year) | 98.28% |
Gross Margin (Trailing Twelve Months) | 98.53% |
Gross Margin (5 Year) | 98.55% |
Operating Margin | |
Operating Margin (Last Fiscal Year) | 112.92% |
Operating Margin (Trailing Twelve Months) | 111.10% |
Operating Margin (5 Year) | 92.07% |
Net Profit Margin | |
Net Profit Margin (Last Fiscal Year) | 96.64% |
Net Profit Margin (Trailing Twelve Months) | 87.79% |
Net Profit Margin (5 Year) | 82.24% |
Growth | |
---|---|
Book Value | |
Book Value Per Share (5 Year) | 2.26% |
Tangible Book Value (5 Year) | 19.24% |
Free Operating Cash Flow | |
Free Operating Cash Flow (5 Year) | -99,999.99% |
Revenue | |
Revenue Change MRQ vs 1 Year Ago | 15.60% |
Revenue Growth (3 Year) | 23.67% |
Revenue Change (Trailing Twelve Months) | 16.81% |
Revenue Per Share Growth | 6.07% |
Revenue Growth (5 Year) | 17.45% |
Capital Spending Debt | |
Capital Spending (5 Year) | -2.78% |
Total Debt (5 Year) | 48.75% |
Dividends | |
Dividend Growth (3 Year) | 1.44% |
Earnings Per Share | |
EPS Change MRQ vs 1 Year Ago | -4.65% |
EPS Change (Trailing Twelve Months) | 180.64% |
EPS Growth (3 Year) | 6.59% |
EPS Growth (5 Year) | 9.32% |
EBITDA | |
EBITDA (5 Year) | 25.14% |
EBITDA (5 Year Interim) | 23.29% |
Net Profit Margin | |
Net Profit Margin Growth (5 Year) | 0.49% |
Valuation | |
---|---|
Total Price to Book | |
Price to Tangible Book (Last Fiscal Year) | 1 |
Price to Tangible Book (Most Recent Quarter) | 1 |
Price to Free Cash Flow | |
Price to Free Cash Per Share (Last Fiscal Year) | 170 |
Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
Net Debt | |
Net Debt (Most Recent Quarter) | 175.8M |
Net Debt (Last Fiscal Year) | 170.5M |
Price to Sales | |
Price to Sales (Last Fiscal Year) | 7 |
Price to Sales (Trailing Twelve Months) | 7 |
Price to Earnings | |
PE Excluding Extraordinary Items (Last Fiscal Year) | 8 |
PE Normalized (Last Fiscal Year) | 8 |
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 7 |
PE Excluding Extraordinary Items High (Trailing Twelve Months) | 22 |
PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 7 |
PE Including Extraordinary Items (Trailing Twelve Months) | 8 |
Dividends | |
Dividend Yield (5 Year) | 4.94% |
Dividend Yield | 7.82% |
Current Dividend Yield | 6.17% |
Price to Book | |
Price to Book (Last Fiscal Year) | 1 |
Price to Book (Most Recent Quarter) | 1 |
Financial Strength | |
---|---|
Debt to Equity | |
Long Term Debt to Equity (Last Fiscal Year) | 38 |
Long Term Debt to Equity (Most Recent Quarter) | 38 |
Payout Ratio | |
Payout Ratio (Last Fiscal Year) | 57.45% |
Payout Ratio (Trailing Twelve Months) | 29.48% |
Quick Ratio | |
Quick Ratio (Last Fiscal Year) | -100,000 |
Quick Ratio (Most Recent Quarter) | -100,000 |
Enterprise Value | |
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
Current Ratio | |
Current Ratio (Last Fiscal Year) | 1 |
Current Ratio (Most Recent Quarter) | 2 |
Free Cash Flow | |
Free Cash Flow (Last Fiscal Year) | 2.2M |
Free Cash Flow (Trailing Twelve Months) | -381,000 |
Net Interest Coverage | |
Net Interest Coverage (Last Fiscal Year) | -100,000 |
Net Interest Coverage (Trailing Twelve Months) | -100,000 |
Total Debt to Equity | |
Total Debt to Equity (Last Fiscal Year) | 38 |
Total Debt to Equity (Most Recent Quarter) | 38 |
Management Effectiveness | |
---|---|
Return on Assets | |
Return on Assets (Last Fiscal Year) | 7.73% |
Return on Assets (Trailing Twelve Months) | 7.04% |
Return on Assets (5 Year) | 6.48% |
Return on Equity | |
Return on Equity (Last Fiscal Year) | 10.57% |
Return on Equity (Trailing Twelve Months) | 9.90% |
Return on Equity (5 Year) | 8.18% |
Return on Investment | |
Return on Investment (Last Fiscal Year) | 7.92% |
Return on Investment (Trailing Twelve Months) | 7.12% |
Return on Investment (5 Year) | 6.60% |